Skip to content
★ Sign in to follow
ME

MediRätt Stock: price and insider trades · Sweden

ISIN SE0003656834SE·

No insider purchase over the last 90 days. The latest, by Carl Johan Merner, was filed 29 May 2018.

MediRätt: what insiders have been doing

MediRätt is a listed company. Filings by its managers are published through Finansinspektionen. MediRätt has had no insider filing for more than a year; the last one goes back to 29 May 2018.

Our records for MediRätt go back to 2017, with 6 purchases and no sales on the open market in total.

In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€91,274
6 ops. · all time
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 29 May 2018
Declarations6 total
  • ▲
    VDExecutives
    51,440 SEK23FI-SE
    8,000 shares@ SEK 6.435.5% of flowISIN SE0003656834FI:csv-7af6da53423caf7076f3
    Canonical exit: 26 Aug 2018 (T+90)
  • ▲
    VDMediExecutives
    38,100 SEK2FI-SE
    6,000 shares@ SEK 6.354.1% of flowISIN SE0003656834FI:csv-c1ff5bea456abd0ef713
    Canonical exit: 26 Aug 2018 (T+90)
  • ▲
    VDExecutives
    18,900 SEK22FI-SE
    3,000 shares@ SEK 6.302.0% of flowFI:csv-f500c6330a8c22f120e6
    Canonical exit: 23 Aug 2018 (T+90)
  • ▲
    VDExecutives
    750,000 SEK30FI-SE
    50,000 shares@ SEK 15.0082.2% of flowFI:csv-814b511e6f751a441d58
    Canonical exit: 22 May 2018 (T+90)
  • ▲
    VDExecutives
    14,600 SEK22FI-SE
    2,000 shares@ SEK 7.301.6% of flowFI:csv-a8c7d5af6c41f0995e66
    Canonical exit: 16 May 2018 (T+90)
  • ▲
    VDExecutives
    39,500 SEK22FI-SE
    5,000 shares@ SEK 7.904.6% of flowFI:csv-b124ddc891fc5958d82f
    Canonical exit: 29 Nov 2017 (T+90)

6 of 6 declarations

About MediRätt

MediRätt is a company listed on the XSTO exchange, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance medical care.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations